BackEPIRUS Biopharmaceuticals Overview

EPIRUS Biopharmaceuticals Total Liabilities

EPIRUS Biopharmaceuticals total liabilities — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
N/A

Peer average

Loading

EPIRUS Biopharmaceuticals Total Liabilities History

Loading

EPIRUS Biopharmaceuticals vs. peers: Total Liabilities Comparison

Loading

EPIRUS Biopharmaceuticals Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

EPIRUS Biopharmaceuticals (EPRSQ) FAQ

Stockcircle tracks total liabilities for EPIRUS Biopharmaceuticals (EPRSQ), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Total Liabilities page is built for EPIRUS Biopharmaceuticals's historical total liabilities trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use total liabilities as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main EPRSQ overview so you can move from this figure to the surrounding analysis quickly.